StockNews.AI
GEHC
StockNews.AI
49 days

GE HealthCare announces cash dividend for second quarter of 2025

1. GE HealthCare declared a $0.035 cash dividend per share for Q2 2025. 2. The dividend is payable on August 15, 2025, to shareholders of record as of July 25. 3. GE HealthCare continues to innovate in healthcare technology and diagnostics. 4. The company aims to improve healthcare efficiency and patient outcomes. 5. GE HealthCare is recognized among Fortune's Most Admired Companies for 2025.

3m saved
Insight
Article

FAQ

Why Bullish?

The announcement of a dividend indicates financial health and shareholder value, which can enhance investor confidence, similar to past dividend declarations by established firms driving stock appreciation.

How important is it?

Announcing a dividend indicates strength and stability, impacting investment decisions and often leading to increased market activity.

Why Short Term?

Immediate sentiment boost from the dividend declaration typically results in short-term trading activity and potential price upticks.

Related Companies

CHICAGO--(BUSINESS WIRE)-- The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

Related News